Clinical Trial Update: Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety, tolerability, and efficacy of ISIS-PTP1BRx in people with type 2 diabetes mellitus and obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• ISIS-PTP1BRx

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Type 2 Diabetes Mellitus, Obese | Phase 2 | Status: COMPLETED